Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB00441"
| Predicate | Value (sorted: none) |
|---|---|
| owl:sameAs | |
| drugbank:interactsWith | |
| owl:sameAs | |
| drugbank:drugCategory | |
| drugbank:interactsWith | |
| owl:sameAs | |
| owl:sameAs | |
| owl:sameAs | |
| drugbank:interactsWith | |
| owl:sameAs | |
| rdfs:label |
"Gemcitabine"
|
| drugbank:drugCategory | |
| owl:sameAs | |
| owl:sameAs | |
| owl:sameAs | |
| owl:sameAs | |
| drugbank:interactsWith | |
| owl:sameAs | |
| drugbank:interactsWith | |
| owl:sameAs | |
| rdf:type | |
| drugbank:interactsWith | |
| drugbank:drugCategory | |
| owl:sameAs | |
| owl:sameAs | |
| drugbank:interactsWith | |
| drugbank:description |
"Gemcitabine is a nucleoside analog used as chemotherapy. It is marketed as Gemzar® by Eli Lilly and Company. As with fluorouracil and other analogues of pyrimidines, the drug replaces one of the building blocks of nucleic acids, in this case cytidine, during DNA replication. The process arrests tumor growth, as new nucleosides cannot be attached to the "faulty" nucleoside, resulting in apoptosis (cellular "suicide").
Gemcitabine is used in various carcinomas: non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer. It is being investigated for use in oesophageal cancer, and is used experimentally in lymphomas and various other tumor types."
|
| owl:sameAs | |
| drugbank:interactsWith | |
| owl:sameAs | |
| drugbank:drugCategory | |
| drugbank:drugCategory | |
| owl:sameAs | |
| owl:sameAs | |
| owl:sameAs | |
| owl:sameAs |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt
The resource appears as object in 18 triples